Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

PRICO: OPTI Target Range

NCT: NCT06207994 · COMPLETED

NCT IDNCT06207994
StatusCOMPLETED
Start Date2024-02-20
Completion2025-11-30
SponsorCzech Technical University in Prague (OTHER)
First posted
Last updated

Brief Summary

The aim of the study is to determine if a narrower SpO2 Target Range setting automated control of FiO2 (A-FiO2) is more effective than a wider SpO2 Target Range

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑